SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-97-010649
Filing Date
1997-12-29
Accepted
1997-12-29 00:00:00
Documents
11
Period of Report
1997-09-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 228342
2 COMMON STOCK PURCHASE WARRANT EX-10.16 46710
3 STOCK SUBSCRIPTION AGREEMENT EX-10.32 2515
4 LICENSE AND SERVICES AGREEMENT EX-10.33 17468
5 STOCKHOLDERS AGREEMENT EX-10.34 94086
6 CONVERTIBLE STOCK PURCHASE AGREEMENT EX-10.35 58368
7 COLLABORATIVE RESEARCH AND LICENSE AGREEMENT EX-10.36 81949
8 SUBSIDIARIES OF THE COMPANY EX-21 220
9 CONSENT OF KPMG PEAT MARWICK EX-23 1117
10 FINANCIAL DATA SCHEDULE EX-27 2057
11 CAUTIONARY FACTORS EX-99 42696
  Complete submission text file 0000950123-97-010649.txt   578131
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 97745377
SIC: 2835 In Vitro & In Vivo Diagnostic Substances